Biotech startup wants to make new short-acting psychedelic drugs more accessible
sociable.co
sociable.co
This is already the most common psychedelic found in nature. It's molecularly very similar to psilocybin and very short acting. Why all the hoopla about engineering novel derivatives that don't carry the safety record of DMT?